Please assess the completion status of the following clinical trial:

Trial Title: A Safety And Tolerability Study Of Valaciclovir Oral Suspension In Infants And Children

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 5.0

Eligibility Criteria:
Inclusion criteria:~* Subjects who have a current herpes virus infection.~* Have neonatally acquired herpes at risk of potential recurrence.~* Immunocompromised or cancer patients at risk for development of a herpes virus infection.~Exclusion criteria:~* Hypersensitivity to antiherpetic medications.~* Impaired hepatic or renal function.~* Show presence of other serious or unstable underlying disease.

- Gender: ALL
- Minimum Age: 1 Month
- Maximum Age: 6 Years
- Healthy Volunteers: f

Study Arms:
- Cohort 1 (Type: EXPERIMENTAL): Subjects in the age group of 2 to less than 6 years will be included
- Cohort 2 (Type: EXPERIMENTAL): Subjects in the age group of 1 to less than 2 years will be included
- Cohort 3 (Type: EXPERIMENTAL): Subjects in the age group of 6 months to less than 1 year will be included
- Cohort 4 (Type: EXPERIMENTAL): Subjects in the age group of 3 months to less than 6 months will be included
- Cohort 5 (Type: EXPERIMENTAL): Subjects in the age group of 1 month to less than 3 months will be included

Based on this trial design, predict the completion outcome and termination type (if applicable).